niacinamide serum
Selected indexed studies
- Niacinamide: a review on dermal delivery strategies and clinical evidence. (Drug Deliv Transl Res, 2024) [PMID:38722460]
- Evaluation of the Efficacy of a Serum Containing Niacinamide, Tranexamic Acid, Vitamin C, and Hydroxy Acid Compared to 4% Hydroquinone in the Management of Melasma. (J Cosmet Dermatol, 2025) [PMID:40062688]
- The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (Cell Metab, 2022) [PMID:35235774]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Niacinamide: a review on dermal delivery strategies and clinical evidence. (2024) pubmed
- Evaluation of the Efficacy of a Serum Containing Niacinamide, Tranexamic Acid, Vitamin C, and Hydroxy Acid Compared to 4% Hydroquinone in the Management of Melasma. (2025) pubmed
- The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (2022) pubmed
- Nicotinic acid riboside maintains NAD(+) homeostasis and ameliorates aging-associated NAD(+) decline. (2025) pubmed
- Roseburia hominis improves host metabolism in diet-induced obesity. (2025) pubmed
- Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway. (2024) pubmed
- Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. (2020) pubmed
- Nicotinamide Attenuates Complement and Coagulation Pathways and Resultant Renal Fibrosis. (2025) pubmed
- Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. (2018) pubmed
- Efficacy and tolerability of a depigmenting gel serum comprising tranexamic acid, niacinamide, 4-butylresorcinol, phytic acid, and a mixture of hydroxy acids that targets the biological processes regulating skin melanogenesis. (2024) pubmed